U

University of Miami | Schiff Center For Liver Diseases

Research site
(Unclaimed)
Location
1500 NW 12th Avenue, Suite 1101-E, Miami, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching)...

Enrolling
PBC
Primary Biliary Cholangitis
Drug: Volixibat
Drug: Placebo

Trial conditions

Fatty Liver (5 trials)
Non-alcoholic Fatty Live... (5 trials)
Hepatitis C (3 trials)
Biliary Liver Cirrhosis (2 trials)
Cholangitis (2 trials)
Fibrosis (2 trials)
Hepatitis (2 trials)
Hepatitis A (2 trials)
Carcinoma (1 trial)
Chronic Hepatitis C (1 trial)

And 3 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems